Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

INTRODUCTION: Due to the high cost and high failure rate of ascertaining amyloid positron emission tomography positivity (PET+) in patients with earlier stage Alzheimer’s disease (AD), an effective pre-screening tool for amyloid PET scans is needed. METHODS: Patients with mild cognitive impairment (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Szu-Ying, Lin, Kun-Ju, Lin, Po-Chen, Huang, Chin-Chang, Chang, Chiung-Chih, Lee, Yi-Chung, Hsiao, Ing-Tsung, Yen, Tzu-Chen, Huang, Wen-Sheng, Yang, Bang-Hung, Wang, Pei-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933740/
https://www.ncbi.nlm.nih.gov/pubmed/31881963
http://dx.doi.org/10.1186/s13195-019-0566-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933740/
https://www.ncbi.nlm.nih.gov/pubmed/31881963
http://dx.doi.org/10.1186/s13195-019-0566-0

Ejemplares similares